NEW YORK (GenomeWeb) – Amyris, an industrial bioscience company, is partnering with synthetic biology firm Genome Compiler to integrate its automated laboratory services with Genome Compiler's online design tools that enable users to design and order DNA and other biological products seamlessly.
According to the companies, customers will have access to both Genome Compiler's software tools and Amyris' libraries of verified genetic parts, DNA construction, and editing methods. The combined solutions will provide a comprehensive, automated DNA design and construction service that is more cost-effective than current offerings, they said.
The partnership "offers some of Amyris' proprietary automated DNA engineering services to pharmaceutical and other biotech companies for scientific discovery and creates opportunities for a new revenue stream for our best-in-class technology platform," Joel Cherry, Amyris president of research and development, said in a statement.
"Adding Amyris' advanced services to our providers' portfolio will provide the pharma and biotech industries with a comprehensive platform for all their synthetic biology needs," Omri Amirav Drory, CEO of Genome Compiler, said. "Customers would benefit from direct connections to an array of DNA synthesis providers and automation facilities, and from an extensive suite of advanced bioinformatics tools and genetic repositories, all in one platform."
The partnership is funded in part by a grant from the Binational Industrial Research and Development Foundation, a US-Israeli partnership between private sectors to expand private high-tech industries.